Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
复制标题
15-脱氧-delta12,14-PGJ2 的生物合成和 PPARgamma 的连接。
DOI:
10.1172/jci18012
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
FitzGerald,GarretA
中科院分区:
文献类型:
--
作者:
Bell-Parikh,LChastine;Ide,Tomomi;Lawson,JohnA;McNamara,Peter;Reilly,Muredach;FitzGerald,GarretA
15-deoxy-Δ12,14-PGJ2(15d-PGJ2) has been identified as an endogenous ligand for PPARγ, inducing adipogenesis in vitro. Additional roles for this molecule in the propagation and resolution of inflammation, ligation of NF-κB, and mediation of apoptosis have been proposed. However, quantitative, physiochemical evidence for the formation of 15d-PGJ2in vivo is lacking. We report that 15d-PGJ2is detectable using liquid chromatography–mass spectrometry–mass spectrometry at low picomolar concentrations in the medium of 3T3-L1 preadipocytes. However, despite induction of COX-2, production of PGs, including 15d-PGJ2, does not increase during adipocyte differentiation, a process unaltered by COX inhibition. 15d-PGJ2is detectable as a minor product of COX-2 in human urine. However, its biosynthesis is unaltered during or after COX activation in vivo by LPS. Furthermore, the biosynthesis of 15d-PGJ2is not augmented in the joint fluid of patients with arthritis, nor is its urinary excretion increased in patients with diabetes or obesity. 15d-PGJ2is not the endogenous mediator of PPARγ-dependent adipocyte activation and is unaltered in clinical settings in which PPARγ activation has been implicated.